Publication | Closed Access
A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer
22
Citations
0
References
2011
Year
OncologyMedicinePathologyColorectal CancerMetastatic Colorectal CancerPhase L/liCancer TreatmentPharmacologyRadiation OncologyMolecular OncologyBibf 1120
No additional data available for this publication yet. Check back later!